This is a paid press release. Contact the press release distributor directly with any inquiries.
PR Newswire
7 min read
In consultation with U.S. stock exchanges, Reverse Stock Split prepares Curaleaf for uplisting, in response to U.S. cannabis rescheduling
, /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that a 1-for-3 reverse stock split of its shares will become effective on or about June 5, 2026 (the “Reverse Stock Split”). Curaleaf’s Board of Directors (the “Board”) has approved a proposal to effect a reverse stock split of the Company’s subordinate voting shares at a ratio of one post-consolidation share for each three pre-consolidation shares (the “Reverse Stock Split”). This initiative is being done in consultation with major U.S. stock exchanges, and is expected to enable the Company to uplist as soon as the opportunity is available.
The Reverse Stock Split will reduce the number of issued and outstanding subordinate voting shares and is expected to increase the trading price per share. The Board has approved the Reverse Stock Split to ensure the Company meets share price level criteria established by U.S. exchanges, as ongoing regulatory developments may provide an opportunity to uplist to a U.S. stock exchange. The Reverse Stock Split is also intended to ensure the Company’s shares trade above limits set by certain retail brokerage firms, and to broaden institutional investor participation.
“This important step is part of Curaleaf’s long-term effort to achieve the listing of our shares to a major U.S. stock exchange,” said Boris Jordan, Chairman and CEO of Curaleaf. “Rescheduling of medical cannabis has created a potential pathway toward uplisting to a major U.S. exchange, and we’re now more prepared than ever. With a hearing on the full rescheduling of cannabis expected to end in July, and U.S. Treasury guidance supporting the normalization of the industry forthcoming, we believe there will soon be greater clarity around the regulatory and tax framework for our industry. These developments should improve access to capital, broaden the investor base, and further legitimize cannabis in the public markets. We are preparing today to move quickly and decisively when that opportunity comes into view.”
For more information, investors can review Curaleaf’s Reverse Stock Split FAQ page here: LINK
Further Information Regarding the Reverse Stock Split
As discussed above, the Company’s Board of Directors has approved a proposal to effect a Reverse Stock Split of the Company’s subordinate voting shares at a ratio of 1-for-3. The Reverse Stock Split has received TSX conditional approval, and it is expected to take effect on or about June 5, 2026 (the “Effective Date”). The Company expects to begin trading on the Toronto Stock Exchange on a post-Reverse Stock Split basis on such Effective Date. Upon completion of the Share Consolidation, the Company’s subordinate voting shares will continue to trade on the TSX under the symbol “CURA”.
